SEC Form 4 · accession 0001562180-17-003380
BIO-TECHNE Corp · TECH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin S Gould
Officer — SVP Clinical Controls
Period of report
Oct 26, 2017
Accepted (ET)
Oct 30, 2017 · 4:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000842023
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 1,355 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF2,F3 | — | Oct 26, 2017 | A | 1,949 | A | — | — | Common Stock | 1,949 | 1,949 | D |
| Stock Options (Right to buy)F3 | $125.05 | Oct 26, 2017 | A | 10,742 | A | — | Aug 9, 2024 | Common Stock | 10,742 | 10,742 | D |
| Stock Options (Right to buy)F4 | $125.05 | Oct 26, 2017 | A | 14,323 | A | — | Aug 9, 2024 | Common Stock | 14,323 | 14,323 | D |
| Restricted Stock UnitsF2,F5 | — | holding | — | — | — | — | — | Common Stock | 2,111 | 2,111 | D |
| Stock Options (Right to Buy)F6 | $106.59 | holding | — | — | — | — | Aug 18, 2023 | Common Stock | 17,371 | 17,371 | D |
| Stock Options (Right to Buy)F5 | $106.59 | holding | — | — | — | — | Aug 18, 2023 | Common Stock | 13,028 | 13,028 | D |
| Stock Options (Right to Buy)F7 | $97.23 | holding | — | — | — | — | Jul 9, 2022 | Common Stock | 50,000 | 50,000 | D |
| Stock Options (Right to Buy)F8 | $97.23 | holding | — | — | — | — | Jul 9, 2022 | Common Stock | 15,000 | 15,000 | D |
| Stock Options (Right to Buy)F9 | $88.23 | holding | — | — | — | — | Jan 4, 2023 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1Includes 834 shares of restricted stock units that vest on 7/9/18.
- F2Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- F3Vests in full or in part on 8/9/2020 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F4Vests 3,580 shares on 8/9/2018 and 3,581 shares each on 8/9/2019, 8/9/2020, 8/9/2021.
- F5Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F6Vests 4,343 shares on each of 8/18/17, 8/18/18 and 8/18/19, and 4,342 shares on 8/18/20.
- F750,000 common stock options vest if certain performance goals are achieved for the 12 months ending 05/31/18.
- F8Vests as to 3,750 shares on each of 7/9/16, 7/9/17, 7/9/18 and 7/9/19.
- F9Vests as to 2,500 shares on each of 01/04/17, 01/04/18, 01/04/19 and 01/04/20.